ndc tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Blood sugar drug tirzepatide also

Mounjaro (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

Reports of previously existing pigmented lesions are common

They were originally developed for diabetes and weight management, but other "off label" uses are becoming more mainstream

Healthcare continues to grow as a percentage of GDP & the rampant inefficiencies are coming along for the ride